Literature DB >> 22807606

How can portal vein cavernous transformation cause chronic incomplete biliary obstruction?

Ozgur Harmanci1, Yusuf Bayraktar.   

Abstract

Biliary disease in the setting of non-cirrhotic portal vein thrombosis (and similarly in portal vein cavernous transformation) can become a serious problem during the evolution of disease. This is mostly due to portal biliary ductopathy. There are several mechanisms that play a role in the development of portal biliary ductopathy, such as induction of fibrosis in the biliary tract (due to direct action of dilated peribiliary collaterals and/or recurrent cholangitis), loss of biliary motility, chronic cholestasis (due to fibrosis or choledocholithiasis) and increased formation of cholelithiasis (due to various factors). The management of cholelithiasis in cases with portal vein cavernous transformation merits special attention. Because of a heterogeneous clinical presentation and concomitant pathophysiological changes that take place in biliary anatomy, diagnosis and therapy can become very complicated. Due to increased incidence and complications of cholelithiasis, standard treatment modalities like sphincterotomy or balloon sweeping of bile ducts can cause serious problems. Cholangitis, biliary strictures and hemobilia are the most common complications that occur during management of these patients. In this review, we specifically discuss important issues about bile stones related to bile duct obstruction in non-cirrhotic portal vein thrombosis and present evidence in the current literature.

Entities:  

Keywords:  Cholelithiasis; Hemobilia; Portal biliopathy; Portal ductopathy; Portal vein cavernous transformation

Mesh:

Year:  2012        PMID: 22807606      PMCID: PMC3396189          DOI: 10.3748/wjg.v18.i26.3375

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  30 in total

1.  Revising consensus in portal hypertension: report of the Baveno V consensus workshop on methodology of diagnosis and therapy in portal hypertension.

Authors:  Roberto de Franchis
Journal:  J Hepatol       Date:  2010-06-27       Impact factor: 25.083

2.  Induced hypotension in the management of acute hemobilia during therapeutic ERCP in a patient with portal biliopathy (with videos).

Authors:  Malay Sharma; Chittapuram S Ramesh Babu; Radha K Dhiman; Yogesh Chawla
Journal:  Gastrointest Endosc       Date:  2010-06-19       Impact factor: 9.427

3.  Extrahepatic portal venous obstruction and obstructive jaundice: approach to management.

Authors:  Ritu Khare; Sadiq S Sikora; Gadiyaram Srikanth; Gaur Choudhuri; Vivek A Saraswat; Ashok Kumar; Rajan Saxena; Vinay K Kapoor
Journal:  J Gastroenterol Hepatol       Date:  2005-01       Impact factor: 4.029

4.  Symptomatic portal biliopathy: a single centre experience from the UK.

Authors:  Ye Htun Oo; Simon Olliff; Geoffrey Haydon; Douglas Thorburn
Journal:  Eur J Gastroenterol Hepatol       Date:  2009-02       Impact factor: 2.566

5.  Ultrasonographic assessment of the gallbladder in 21 children with portal vein thrombosis.

Authors:  Roberto M Yamada; Gabriel Hessel
Journal:  Pediatr Radiol       Date:  2004-10-12

6.  Is balloon sweeping detrimental in portal biliopathy? A report of 3 cases.

Authors:  Malay Sharma; Rajesh Prabhu Ponnusamy
Journal:  Gastrointest Endosc       Date:  2009-05-05       Impact factor: 9.427

7.  Imaging features of portal biliopathy: frequency of involvement patterns with emphasis on MRCP.

Authors:  Esra Ozkavukcu; Ayşe Erden; Ilhan Erden
Journal:  Eur J Radiol       Date:  2008-04-29       Impact factor: 3.528

8.  "Portal double ductopathy sign" in patients with portal vein cavernous transformation.

Authors:  Yusuf Bayraktar; Ozgur Harmanci; Osman Ersoy; Musa Aydinli; Ferhun Balkanci
Journal:  Hepatogastroenterology       Date:  2008 Jul-Aug

9.  Terlipressin in control of acute hemobilia during therapeutic ERCP in patient with portal biliopathy.

Authors:  Pankaj Tyagi; Sanjeev Sachdeva; Anil K Agarwal; Amerender S Puri
Journal:  Surg Laparosc Endosc Percutan Tech       Date:  2009-10       Impact factor: 1.719

10.  Vascular biliopathy as a cause of common bile duct obstruction successfully treated by mesocaval shunt and endoscopic retrograde cholangiopancreatography biliary stent placement.

Authors:  Martin D Rosenthal; Geoffrey H White; Michael S Stephen; James J Gallagher; Charbel Sandroussi
Journal:  Vascular       Date:  2008 Nov-Dec       Impact factor: 1.285

View more
  12 in total

1.  Comparative evaluation of magnetic resonance cholangiopancreatography/magnetic resonance splenoportovenography and endoscopic ultrasound in the diagnosis of portal cavernoma cholangiopathy.

Authors:  Gyan Prakash Rai; Sandeep Nijhawan; M P Madhu; Shyam Sundar Sharma; Rupesh Pokharna
Journal:  Indian J Gastroenterol       Date:  2016-01-07

Review 2.  Portal cavernoma cholangiopathy: an endoscopic ultrasound based imaging approach.

Authors:  Malay Sharma; Chittapuram S Rameshbabu
Journal:  J Clin Exp Hepatol       Date:  2013-09-26

3.  Spectrum of biliary abnormalities in portal cavernoma cholangiopathy (PCC) secondary to idiopathic extrahepatic portal vein obstruction (EHPVO)-a prospective magnetic resonance cholangiopancreaticography (MRCP) based study.

Authors:  Shumyla Jabeen; Irfan Robbani; Naseer A Choh; Obaid Ashraf; Feroze Shaheen; Tariq Gojwari; Sabeeha Gul
Journal:  Br J Radiol       Date:  2016-10-12       Impact factor: 3.039

4.  Portal biliary ductopathy caused by cavernous transformation of the portal vein.

Authors:  Jeffrey Chu-Nan Chong; Ray Boyapati; Ferry Rusli
Journal:  BMJ Case Rep       Date:  2013-01-31

Review 5.  Pathogenesis of Portal Cavernoma Cholangiopathy: Is it Compression by Collaterals or Ischemic Injury to Bile Ducts During Portal Vein Thrombosis?

Authors:  Pankaj Puri
Journal:  J Clin Exp Hepatol       Date:  2014-01-02

6.  Portal Cavernoma Cholangiopathy in Children: An Evaluation Using Magnetic Resonance Cholangiography and Endoscopic Ultrasound.

Authors:  Vybhav Venkatesh; Surinder S Rana; Anmol Bhatia; Sadhna B Lal
Journal:  J Clin Exp Hepatol       Date:  2021-03-05

Review 7.  Therapeutic approaches for portal biliopathy: A systematic review.

Authors:  Irene Franceschet; Alberto Zanetto; Alberto Ferrarese; Patrizia Burra; Marco Senzolo
Journal:  World J Gastroenterol       Date:  2016-12-07       Impact factor: 5.742

8.  Hydatid liver cyst causing portal vein thrombosis and cavernous transformation: a case report and literature review.

Authors:  Serdar Kirmizi; Cuneyt Kayaalp; Sezai Yilmaz
Journal:  Gastroenterol Hepatol Bed Bench       Date:  2016

9.  Portal biliopathy treated with endoscopic biliary stenting.

Authors:  Sung Jin Jeon; Jae Ki Min; So Young Kwon; Jun Hyun Kim; Sun Young Moon; Kang Hoon Lee; Jeong Han Kim; Won Hyeok Choe; Young Koog Cheon; Tae Hyung Kim; Hee Sun Park
Journal:  Clin Mol Hepatol       Date:  2016-03-28

10.  Portal Hypertensive Biliopathy: An Infrequent Cause of Biliary Obstruction.

Authors:  Ricardo Cardoso; Adriano Casela; Sandra Lopes; Cláudia Agostinho; Paulo Souto; Ernestina Camacho; Nuno Almeida; Sofia Mendes; Dário Gomes; Carlos Sofia
Journal:  GE Port J Gastroenterol       Date:  2015-03-18
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.